Controlled Study of ONO-1101 in Patients With Postoperative Tachyarrhythmias in Japan

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the efficacy and safety of ONO-1101 in postoperative supraventricular tachyarrhythmias.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ono Pharmaceutical Co. Ltd
• Treatments: Landiolol

Criteria

Inclusion Criteria:

1. 20 years or older

2. Postoperative supraventricular tachyarrhythmias

3. Within 7 days postoperatively

4. Other inclusion criteria as specified in the protocol

Exclusion Criteria:

1. Acute myocardial infarction (within 1 month after onset)

2. Severe heart failure [New York Heart Association (NYHA) functional class III or higher]

3. Atrioventricular block (grade II or higher), or sick sinus syndrome

4. Other exclusion criteria as specified in the protocol